Search

Orthocell unveils IPO plans

Perth-based biotech firm Orthocell has confirmed it intends to list on the ASX after outlining plans for an $8 million initial public offering.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Orthocell (OCC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/06/18

1 year TSR5 year TSR
465thJV Global0%-11%
547thOrthocell-11%0%
655thCoAssets-30%0%
693rdStructural Monitoring Systems-40%111%
762nd333D-59%-34%
722 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

09/05/18
$17k Issued
09/05/18
$20k Issued
09/05/18
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

148th↓Orthocell$1.0m
163rd↓JV Global$487k
164th↑333D$342k
166th↓CoAssets$322k
167th↓Structural Monitoring Systems$312k
239 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Orthocell

256thPaul Anderson$438k
758thStewart Washer$150k
852ndMatt Callahan$120k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer